Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 233, Issue 10, Pages 6344-6351Publisher
WILEY
DOI: 10.1002/jcp.26615
Keywords
apoptosis; calumenin; doxorubicin; ERS; miR378*
Categories
Funding
- natural science foundation of Inner Mongolia [2016BS0806]
- National Natural Science Foundation of China [81760780, 81360587]
- Mongolian medicine systems biology science and technology innovation team plan of Inner Mongolia
Ask authors/readers for more resources
Doxorubicin (Dox) is a highly effective antitumor antibiotic, however myocardial toxicity severely limits its use clinically. The pathogenesis of doxorubicin-induced cardiomyopathy is unclear. In Dox cardiomyopathy mice, there is a decline in cardiac function, a change in myocardial pathology and a reduction in miR378* expression. Expression changes in calumenin, an endoplasmic reticulum stress (ERS) chaperone protein and pathway factor, as well as apoptosis, were observed in cardiomyocytes after doxorubicin-induced injury. However, miR378* increased calumenin expression, eased ERS, and reduced cardiomyocyte apoptosis, while, silencing miR378* reduced calumenin expression, aggravated ERS, and increased cardiomyocyte apoptosis. The above results indicate that miR378* alleviates ERS and inhibits the activation of the ERS-mediated apoptosis signaling pathway in cardiomyocytes via regulating calumenin expression, thereby reducing cardiomyocyte apoptosis after doxorubicin-induced injury. Increasing miR378* expression may be a new way to improve cardiac function and quality of life in patients with Dox cardiomyopathy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available